Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Altaire Pharmaceuticals, Inc.
FDA Inspection
•Altaire Pharmaceuticals, Inc.•February 11, 2022

Altaire Pharmaceuticals, Inc. – FDA Inspection, Feb 11, 2022

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on February 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Altaire Pharmaceuticals, Inc.
Inspection Date
February 11, 2022
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 0c20c70c-b178-4306-8b90-55ba5c3ee376

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1162640
FDA center
Human Drugs
Project area
Drug Quality Assurance

Other FDA inspections of Altaire Pharmaceuticals, Inc.

13
DateClassificationOfficeProject area
April 21, 2026Not classifiedNew York District OfficeDrug Quality Assurance
October 21, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
April 19, 2019OAICenter for Veterinary MedicineGeneric Drug Evaluation
March 9, 2017VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
December 15, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Altaire Pharmaceuticals, Inc.
  • FDA Inspection 1314330 - 2026-04-21
  • FDA Inspection 1251507 - 2024-10-21
  • FDA Inspection 1089315 - 2019-04-19
  • FDA Inspection 1005208 - 2017-03-09
  • FDA Inspection 955795 - 2015-12-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altaire Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.